The firm's financial position is increasingly vulnerable, with retained earnings plummeting to -$27.2 million and total assets shrinking to $11.2 million as of 2025Q4.
| Total Current Assets | 11.06M | 8K | 63.13K | 741.81K |
| Cash & Short-Term Investments | - | - | - | - |
| Cash Only | - | - | - | - |
| Short-Term Investments | - | - | - | - |
| Accounts Receivable | - | - | - | - |
| Days Sales Outstanding | - | - | - | - |
| Inventory | - | - | - | - |
| Days Inventory Outstanding | - | - | - | - |
| Other Current Assets | 2.98M | 0 | 0 | 0 |
| Total Non-Current Assets | 115.76K | 18.06M | 50.88M | 61.23M |
| Property, Plant & Equipment | 101.22K | 0 | 0 | 0 |
| Fixed Asset Turnover | 59.09x | - | - | - |
| Goodwill | 0 | 0 | 0 | 0 |
| Intangible Assets | 0 | 0 | 0 | 0 |
| Long-Term Investments | 0 | 18.06M | 50.88M | 70.42M |
| Other Non-Current Assets | - | - | - | - |
| Total Assets | 11.17M | 18.06M | 50.94M | 61.97M |
| Asset Turnover | 0.54x | - | - | - |
| Asset Growth % | -38.15% | -64.54% | -17.79% | - |
| Total Current Liabilities | 686.82K | 1.75M | 387.95K | 257.87K |
| Accounts Payable | 0 | 488.31K | 213.12K | 248.03K |
| Days Payables Outstanding | - | - | - | - |
| Short-Term Debt | 57.35K | 1.13M | 165K | 0 |
| Deferred Revenue (Current) | - | - | - | - |
| Other Current Liabilities | 629.47K | 0 | 9.84K | 0 |
| Current Ratio | 16.10x | 0.00x | 0.16x | 2.88x |
| Quick Ratio | 16.10x | 0.00x | 0.16x | 2.88x |
| Cash Conversion Cycle | - | - | - | - |
| Total Non-Current Liabilities | 59.56K | 0 | 50.88M | 70.38M |
| Long-Term Debt | 52.75K | 0 | 0 | 0 |
| Capital Lease Obligations | - | - | - | - |
| Deferred Tax Liabilities | - | - | - | - |
| Other Non-Current Liabilities | - | - | - | - |
| Total Liabilities | 746.38K | 1.75M | 387.95K | 171.15K |
| Total Debt | 110.1K | 1.13M | 165K | 0 |
| Net Debt | -6.89M | 1.13M | 136.44K | -659.03K |
| Debt / Equity | 0.01x | 0.07x | 0.00x | - |
| Debt / EBITDA | - | 0.66x | 0.06x | - |
| Net Debt / EBITDA | - | 0.66x | 0.05x | - |
| Interest Coverage | -20.52x | - | - | - |
| Total Equity | 10.43M | 16.31M | 50.56M | 61.79M |
| Equity Growth % | -36.08% | -67.74% | -18.19% | - |
| Book Value per Share | 0.57 | 4.23 | 5.52 | 6.73 |
| Total Shareholders' Equity | 10.43M | 16.31M | 50.56M | 70.93M |
| Common Stock | 2.26K | 18.06M | 50.88M | 70.38M |
| Retained Earnings | -27.23M | -1.75M | -325.05K | -42.58K |
| Treasury Stock | 0 | 0 | 0 | 0 |
| Accumulated OCI | 0 | 0 | 0 | 0 |
| Minority Interest | 0 | 0 | 0 | 0 |
Imminent Liquidation Deadline Risk
As reported in recent financial statements, AlphaVest's total assets have declined from $73.1 million in 2023Q3 to $11.2 million by 2025Q4, signaling a significant contraction in the firm's capital base as it struggles to maintain its viability without a completed business combination.
The consistent downward trend in total assets suggests that the entity is consuming its trust capital to fund ongoing administrative and compliance costs. This trajectory indicates that the firm's ability to attract a high-quality target may be diminishing as the available capital pool shrinks.
Based on the 2025Q4 balance sheet, the company reports a current ratio of 16.10, yet this figure is misleading as the cash position of $7.0 million is largely restricted and must cover substantial outstanding liabilities and potential shareholder redemptions before any merger can occur.
While the current ratio appears high, the underlying liquidity is constrained by the structural requirements of a SPAC. Investors should monitor the cash-to-liability ratio closely, as the firm's ability to meet its obligations without further sponsor support appears increasingly precarious.
According to historical balance sheet data, retained earnings have plummeted to -$27.2 million by 2025Q4, reflecting the persistent operational losses that have significantly eroded the equity base since the company's inception in 2022.
The rapid depletion of retained earnings suggests that the firm's search for a target has been inefficient and costly. This erosion of equity may limit the sponsor's flexibility in structuring a future deal, potentially necessitating dilutive financing to complete a business combination.
As indicated by the 2025Q4 data, the presence of $746.4K in total liabilities against a shrinking asset base suggests that the actual pro-rata value available to shareholders upon liquidation may be lower than the headline $10.00 per share assumption.
The accumulation of liabilities relative to the remaining trust assets warrants further investigation into the priority of claims in a liquidation scenario. This distortion suggests that the downside protection typically associated with SPACs may be weaker than market participants currently anticipate.
Quick answers to the most common questions about buying ATMV stock.
As of 2025, AlphaVest Acquisition Corp (ATMV) had total assets of $11.2M including $11.1M in current assets.
AlphaVest Acquisition Corp (ATMV) carries total debt of $0.1M. Comparing total debt to cash helps evaluate the company's debt burden and net leverage.
AlphaVest Acquisition Corp (ATMV) has total shareholders' equity (book value) of $10.4M ($0.57 book value per share). Book value represents the net worth of the company belonging to common stock holders.
AlphaVest Acquisition Corp (ATMV) reported a current ratio of 16.10x. A current ratio above 1.0x indicates that the company has more current assets than current liabilities, suggesting sufficient short-term liquidity.